3SBio (HKG:1530) is seeking HK$3.12 billion via a stock offering, according to a Hong Kong bourse filing Tuesday.
Shares of the company declined over 4% in Tuesday's morning trade.
The company is seeking investors for around 105.2 million shares priced at HK$29.62 each to raise funds for advancing its drug portfolio.
The shares represent 4.32% of the company's issued share capital and 4.14% as enlarged by the sale.